Patient and Relative Experiences and Decision-making About Genetic Testing and Counseling for Familial ALS and FTD
- 31 May 2021
- journal article
- review article
- Published by Wolters Kluwer Health in Alzheimer Disease & Associated Disorders
- Vol. 35 (4) , 374-385
Abstract
Genetic testing and counseling is an emerging part of care for patients with amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD) and their families. This scoping review aimed to map patients’ and relatives’ experiences of genetic testing and counseling for familial ALS and FTD and the factors influencing their decision to proceed with testing or counseling. Informed by the Joanna Briggs Institute methodology, 5 databases were systematically searched. Thirty studies from 39 references were included. A descriptive numerical summary analysis and narrative synthesis was conducted. Mostly positive diagnostic testing experiences were reported, but issues arose due to progressive disease and discordant results. Predictive testing impacted at-risk relatives, regardless of the result received, and psychosocial sequelae ranged from relief to guilt, worry or contemplating suicide. Four reproductive testing experiences were reported. Personal, familial and practical factors, and the lived experience of disease, informed decision-making. Greater uncertainty and complexity may be faced in familial ALS/FTD than in other late-onset neurodegenerative diseases due to clinical and genetic heterogeneity, and testing limitations. Genetic counseling models of care should consider this difference to ensure that individuals with, or at risk of, ALS/FTD are effectively managed. Implications for research and practice are discussed.Keywords
This publication has 84 references indexed in Scilit:
- Evaluation of exclusion prenatal and exclusion preimplantation genetic diagnosis for Huntington's disease in the NetherlandsClinical Genetics, 2012
- Developing a comprehensive, effective patient-friendly website to enhance decision making in predictive testing for Huntington diseaseGenetics in Medicine, 2012
- Absence of consensus in diagnostic criteria for familial neurodegenerative diseasesJournal of Neurology, Neurosurgery & Psychiatry, 2012
- Genetic counseling for FTD/ALS caused by the C9ORF72 hexanucleotide expansionAlzheimer's Research & Therapy, 2012
- Preimplantation genetic diagnosis (PGD) for Huntington's disease: the experience of three European centresEuropean Journal of Human Genetics, 2011
- Scoping studies: advancing the methodologyImplementation Science, 2010
- A Decade of Genetic Counseling in Frontotemporal Dementia Affected Families: Few Counseling Requests and much Familial Opposition to TestingJournal of Genetic Counseling, 2009
- The roles of family members, health care workers, and others in decision-making processes about genetic testing among individuals at risk for Huntington diseaseGenetics in Medicine, 2007
- Critical Periods of Suicide Risk in Huntington’s DiseaseAmerican Journal of Psychiatry, 2005
- Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosisNature, 1993